News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
832,562 Results
Type
Article (85616)
Company Profile (703)
Press Release (746243)
Section
Business (232033)
Career Advice (4115)
Deals (39668)
Drug Delivery (120)
Drug Development (90651)
Employer Resources (194)
FDA (17942)
Job Trends (17279)
News (395199)
Policy (39597)
Tag
Academia (2972)
Alliances (56537)
Alzheimer's disease (1377)
Approvals (17904)
Artificial intelligence (160)
Bankruptcy (396)
Best Places to Work (12505)
Biotechnology (485)
Breast cancer (190)
Cancer (1417)
Cardiovascular disease (109)
Career advice (3518)
CAR-T (114)
Cell therapy (331)
Clinical research (71919)
Collaboration (534)
Compensation (256)
COVID-19 (2802)
C-suite (121)
Data (1345)
Diabetes (147)
Diagnostics (6640)
Earnings (94379)
Employer resources (166)
Events (127001)
Executive appointments (408)
FDA (18595)
Funding (455)
Gene therapy (235)
GLP-1 (672)
Government (5030)
Healthcare (20697)
Infectious disease (2884)
Inflammatory bowel disease (126)
Interviews (808)
IPO (17617)
Job creations (5179)
Job search strategy (2856)
Layoffs (495)
Legal (10027)
Lung cancer (209)
Manufacturing (217)
Medical device (14305)
Medtech (14310)
Mergers & acquisitions (22141)
Metabolic disorders (464)
Neuroscience (1732)
NextGen: Class of 2025 (7656)
Non-profit (5056)
Northern California (1710)
Obesity (256)
Opinion (251)
Patents (120)
People (64336)
Pharmaceutical (143)
Phase I (22188)
Phase II (31251)
Phase III (23536)
Pipeline (571)
Postmarket research (3541)
Preclinical (9995)
Radiopharmaceuticals (246)
Rare diseases (272)
Real estate (7372)
Regulatory (26064)
Research institute (2640)
Resumes & cover letters (649)
Southern California (1467)
Startups (4277)
United States (15348)
Vaccines (641)
Weight loss (200)
Date
Today (104)
Last 7 days (781)
Last 30 days (1886)
Last 365 days (34441)
2025 (1237)
2024 (34993)
2023 (42569)
2022 (53928)
2021 (58724)
2020 (57670)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1261)
Arizona (223)
Asia (49457)
Australia (8723)
California (3897)
Canada (1310)
China (338)
Colorado (143)
Connecticut (172)
Europe (113217)
Florida (478)
Illinois (404)
Indiana (224)
Kansas (105)
Maryland (680)
Massachusetts (3156)
Michigan (166)
Minnesota (275)
New Jersey (1126)
New York (1081)
North Carolina (862)
Northern California (1710)
Ohio (129)
Pennsylvania (868)
South America (1647)
Southern California (1467)
Texas (520)
Washington State (433)
832,562 Results for "e scape bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Passage Bio Cutting 55% of Staff to Help Extend Cash Runway
Passage Bio’s workforce reduction could affect about 32 people, leaving the company with 26 employees as it continues evaluating a treatment for frontotemporal dementia with granulin mutations.
January 13, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board
November 11, 2024
·
6 min read
Press Releases
Exai Bio Appoints Oncology Leader and Former American Cancer Society CEO, Karen E. Knudsen, MBA, PhD, to its Board of Directors
December 5, 2024
·
2 min read
Press Releases
Vivacelle Bio to Participate in BIO Partnering @ JPM Week 2025
January 10, 2025
·
2 min read
Press Releases
Atavistik Bio Announces Nomination of Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor
October 15, 2024
·
4 min read
Drug Development
Annovis Bio’s Buntanetap Found Safe and Effective in High-Risk Alzheimer’s PatientsJoin Our Investor Call for In-Depth Findings Discussion
Annovis Bio Inc. announces that its recent Phase II/III Alzheimer’s study of its lead drug candidate, Buntanetap, showed statistically significant efficacy and safety in both carriers and non-carriers of Apolipoprotein E4, a genetic cause of AD.
June 11, 2024
·
4 min read
Press Releases
Serna Bio Announces Scientific Advisory Board
January 10, 2025
·
5 min read
Layoffs
Bluebird Bio to Lay Off 25% of Workforce
About a month after reporting it’s had a tough time starting enough patients on its treatments, bluebird bio announced it will lay off about 25% of its employees, over half of whom work in R&D.
September 24, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Mercury Bio Appoints Biotech Innovator Alex Koglin, Ph.D. to Board of Directors
With the addition of NTx’s co-founder and former President to the board Mercury Bio significantly enhances its strategic reach in the biotech sector
October 1, 2024
·
2 min read
Press Releases
Atavistik Bio Presents Preclinical Data on Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor, at EORTC-NCI-AACR Symposium
October 23, 2024
·
3 min read
1 of 83,257
Next
